Improvement and optimization of standards for a preclinical animal test model of laser induced choroidal neovascularization

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Zhu, Yanji ^a   Lu, Qing ^a   Shen, Jikui ^b   Zhang, Ling ^b   Gao, Yushuo ^a   Shen, Xi ^a   Xie, Bing ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 2; INDUCIBLE NITRIC OXIDE SYNTHASE; MESSENGER RNA; PLACENTAL GROWTH FACTOR; VASCULOTROPIN;

AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIODE LASER; DISEASE DURATION; DISEASE MODEL; EXPERIMENTAL MODEL; FEMALE; LASER COAGULATION; MALE; MOUSE; NONHUMAN; OPTIC DISK; SEX DIFFERENCE; STANDARDIZATION; SUBRETINAL NEOVASCULARIZATION; ANIMAL; C57BL MOUSE; CHOROIDAL NEOVASCULARIZATION; LASER; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION;

ANIMALS; CHOROIDAL NEOVASCULARIZATION; DISEASE MODELS, ANIMAL; FEMALE; LASERS; MALE; MICE; MICE, INBRED C57BL; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84899739626     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0094743     Document Type: Article

References (57)

1. Gehrs KM, Anderson DH, Johnson LV, Hageman GS (2006) Agerelated macular degeneration: emerging pathogenetic and therapeutic concepts. Ann Med 38(7):450-71. (Pubitemid 44767496)
2. Hageman GS, Luthert PJ, Victor Chong NH, Johnson LV, Anderson DH, et al. (2011) An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration. Prog Retin Eye Res 20(6):705-32.
3. Freund KB, Yannuzzi LA, Sorenson JA (1993) Age-related macular degeneration and choroidal neovascularization. Am J Ophthalmol 115(6):786-791. (Pubitemid 23171608)
4. Grossniklaus HE, Ling JX, Wallace TM, Dithmar S, Lawson DH, et al. (2002) Macrophage and retinal pigment epithelium expression of angiogenic cytokines in choroidal neovascularization. Mol Vis 8:119-126. (Pubitemid 36153599)
5. Soubrane G (2008) Choroidal neovascularization in pathologic myopia: recent developments in diagnosis and treatment. Surv Ophthalmol 53(2):121-38. doi: 10.1016/j.
6. Prasad AG, Van Gelder RN (2005) Presumed ocular histoplasmosis syndrome. Curr Opin Ophthalmol 16:364-368. (Pubitemid 41735827)
7. Clarkson JG, Altman RD (1982) Angioid streaks. Surv Ophthalmol 26:235-246. (Pubitemid 12117361)
8. Yannuzzi LA, Sorenson J, Spaide RF, Lipson B (1990) Idiopathic polypoidal choroidal vasculopathy (IPCV). Retina 10:1-8. (Pubitemid 20201879)
9. Schlingemann RO (2004) Role of growth factors and the wound healing response in age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 242(1):91-101.
10. Witmer AN, Vrensen GF, Van Noorden CJ, Schlingemann RO (2003) Vascular endothelial growth factors and angiogenesis in eye disease. Prog Retin Eye Res 22 (1):1-29. (Pubitemid 36207453)
11. Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, et al. (1997) Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 4; 277(5322):55-60.
12. Grossniklaus HE, Kang SJ, Berglin L (2010) Animal models of choroidal and retinal neovascularization. Prog Retin Eye Res 29(6):500-519.
13. Ryan SJ (1979) The development of an experimental model of subretinal neovascularization in disciform macular degeneration.Trans Am Ophthalmol Soc77:707-745.
14. Miller H, Miller B (1993) Photodynamic therapy of subretinal neovascularization in the monkey eye. Arch Ophthalmol 111: 855-860. (Pubitemid 23170603)
15. Miller JW, Walsh AW, Kramer M, Hasan T, Michaud N, et al. (1995) Photodynamic therapy of experimental choroidal neovascularization using lipoprotein-delivered benzoporphyrin. Arch Ophthalmol 113: 810-818.
16. Tobe T, Ortega S, Luna JD, Ozaki H, Okamoto N, et al. (1998) Targeted disruption of the FGF2 gene does not prevent choroidal neovascularization in a murine model. Am J Pathol 153:1641-1646. (Pubitemid 28509922)
17. Tomaa HS, Barnett JM, Penna JS, Kim SJ (2010) Improved assessment of laser-induced choroidal neovascularization. Microvasc Res 80(3): 295-302.
18. Rohrer B, Long Q, Coughlin B, Wilson RB, Huang Y, et al. (2009) A targeted inhibitor of the alternative complement pathway reduces angiogenesis in a mouse model of age-related macular degeneration. Invest Ophthalmol Vis Sci 50: 3056-3064.
19. Shen J, Yang X, Xie B, Chen Y, Swaim M, et al. (2008) Micro-RNAs regulate ocular neovascularization. Mol Ther 16(7):1208-16. doi: 10.1038/mt.2008.104.
20. Fujimura S, Takahashi H, Yuda K, Ueta T, Iriyama A, et al. (2012) Angiostatic effect of CXCR3 expressed on choroidal neovascularization. Invest Ophthalmol Vis Sci 18;53(4):1999-2006. doi: 10.1167/iovs.11-8232.
21. Schmittgen TD, Livak KJ (2008) Analyzing Real-time PCR Data by the Comparative CT Method. Nat Protoc 3(6):1101-8 (Pubitemid 351818697)
22. Ando A, Yang A, Mori K, Yamada H, Yamada E, et al. (2002) Nitric oxide is proangiogenic in the retina and choroid. J Cell Physiol 191: 116-124. (Pubitemid 34195223)
23. Ishibashi T, Hata Y, Yoshikawa H, Nakagawa K, Sueishi K, et al. (1997) Expression of vascular endothelial growth factor in experimental choroidal neovascularization. Graefes Arch Clin Exp Ophthalmol 235: 159-167. (Pubitemid 27129479)
24. Jager RD, Mieler WF, Miller JW (2008) Age-related macular degeneration. N Engl J Med 358:2606-2617.
25. Klein R (2007) Overview of progress in the epidemiology of age-related macular degeneration. Ophthalmic Epidemiol 14:184-187.
26. Klein R, Peto T, Bird A, Vannewkirk MR (2004) The epidemiology of age-related macular degeneration. Am J Ophthalmol 137(3):486-495. (Pubitemid 38328641)
27. Grossniklaus HE, Green WR (2004) Choroidal neovascularization. Am J Ophthalmol 137:496-503. (Pubitemid 38328642)
28. Waisbourd M, Loewenstein A, Goldstein M, Leibovitch I (2007) Targeting vascular endothelial growth factor: A promising strategy for treating age-related macular degeneration. Drugs Aging 24:643-662.
29. Ferrara N, Mass RD, Campa C, Kim R (2007) Targeting VEGF-A to treat cancer and age-related macular degeneration. Annu Rev Med 58:491-504. (Pubitemid 46706529)
30. Klein R, Klein BE, Linton KL (1992) Prevalence of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology 99(6):933-43.
31. Mitchell P, Smith W, Attebo K, Wang JJ (1995) Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study. Ophthalmology 102(10):1450-60.
32. Vingerling JR, Dielemans I, Hofman A, Grobbee DE, Hijmering M, et al. (1995) The prevalence of age-related maculopathy in the Rotterdam Study. Ophthalmology 102(2):205-10.
33. Smith W, Mitchell P, Wang JJ (1997) Gender, oestrogen, hormone replacement and age-related macular degeneration: results from the Blue Mountains Eye Study. Aust N Z J Ophthalmol 25 Suppl 1:S13-5. (Pubitemid 27337271)
34. Kobayashi K, Mandai M, Suzuma I, Kobayashi H, Okinami S (2002) Expression of estrogen receptor in the choroidal neovascular membranes in highly myopic eyes. Retina 22(4):418-22. (Pubitemid 35025516)
35. Espinosa-Heidmann DG, Marin-Castano ME, Pereira-Simon S, Hernandez EP, Elliot S, et al. (2005) Gender and estrogen supplementation increases severity of experimental choroidal neovascularization. Exp Eye Res 80(3):413-23. (Pubitemid 40249897)
36. Losordo DW, Isner JM (2001) Estrogen and angiogenesis: a review. Arterioscler Thromb Vasc Biol 21(1):6-12. (Pubitemid 32061922)
37. Albrecht ED, Pepe GJ (2003) Steroid hormone regulation of angiogenesis in the primate endometrium. Front Biosci 8: d416-29. (Pubitemid 38943200)
38. Rubanyi GM, Johns A, Kauser K (2002) Effect of estrogen on endothelial function and angiogenesis. Vascul. Pharmacol 38: 89-98. (Pubitemid 36398281)
39. Garvin S, Dabrosin C (2003) Tamoxifen inhibits secretion of vascular endothelial growth factor in breast cancer in vivo. Cancer Res 63: 8742-8748. (Pubitemid 38064052)
40. Ashcroft GS, Mills SJ, Ashworth JJ (2002) Aging and wound healing. Biogerontology 3(6): 337-45.
41. Grossniklaus HE, Green WR (1998) Histopathologic and ultrastructural findings of surgically excised choroidal neovascularization. Submacular Surgery Trials Research Group. Arch Ophthalmol 116:745-749 (Pubitemid 28292727)
42. Schlingemann RO (2004) Role of growth factors and the wound healing response in age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 242(1):91-101.
43. Ashcroft GS, Mills SJ. (2002) Androgen receptor-mediated inhibition of cutaneous wound healing. J Clin Invest 110:615-24. (Pubitemid 34988785)
44. Fujimoto J, Hori M, Ichigo S, Tamaya T (1997) Ovarian steroids regulate the expression of basic fibroblast growth factor and its mRNA in fibroblasts derived from uterine endometrium. Ann Clin Biochem 34:91-6. (Pubitemid 27067875)
45. Rubanyi GM, Kauser K, Johns A (2002) Role of estrogen receptors in the vascular system. Vascul Pharmacol 38: 81-88. (Pubitemid 36401586)
46. Bird AC (2003) The Bowman lecture. Towards an understanding of age-related macular disease. Eye 17:457-466
47. Holz FG, Sheraidah G, Pauleikhoff D, Bird AC (1994) Analysis of lipid deposits extracted from human macular and peripheral Bruch's membrane. Arch Ophthalmol 112:402-406 (Pubitemid 24085153)
48. Dot C, Parier V, Behar-Cohen F, BenEzra D, Jonet L, et al. (2009) Influence of age in retinochoroidal healing processes after argon photocoagulation in C57bl/6j mice. Mol Vis 15:670-84.
49. Albert DM, Neekhar A, Wang S, Darjatmoko SR, Sorenson CM, et al. (2010) Development of choroidal neovascularizaiton in rats with advanced intense cyclic light-induced retinal degeneration. Arch Ophthalmol 128:212-222.
50. Swift ME, Burns AL, Gray KL, DiPietro LA (2001) Agerelated alterations in the inflammatory response to dermal injury. J Invest Dermatol 117: 1027-35. (Pubitemid 34205894)
51. Feng Y, Pfister F, Schreiter K, Wang Y, Stock O, et al. (2008) Angiopoietin-2 deficiency decelerates age-dependent vascular changes in the mouse retina. Cell Physiol Biochem 21(1-3):129-36.
52. Soybir G, Topuzlu C, Odabaş O, Dolay K, Bilir A, et al. (2003) The effects of melatonin on angiogenesis and wound healing. Surg Today 33:896-901. (Pubitemid 38037347)
53. Feng Y, Pfister F, Schreiter K, Wang Y, Stock O, et al. (2008) Angiopoietin-2 deficiency decelerates age-dependent vascular changes in the mouse retina. Cell Physiol Biochem 21(1-3):129-36.
54. Hoerster R, Muether PS, Vierkotten S, Schröder S, Kirchhof B, et al. (2012) In-vivo and ex-vivo characterization of laser-induced choroidal neovascularization variability in mice. Graefes Arch Clin Exp Ophthalmol 250(11):1579-86. doi: 10.1007/s00417-012-1990-z.
55. Dong Z, Noda K, Kanda A, Fukuhara J, Ando R, et al. (2013) Specific inhibition of serine/arginine-rich protein kinase attenuates choroidal neovascularization. Mol Vis 19:536-43.
56. Kurihara T, Westenskow PD, Bravo S, Aguilar E, Friedlander M (2012) Targeted deletion of Vegfa in adult mice induces vision loss. J Clin Invest 1;122(11):4213-7.
57. Xie P, Zhang W, Yuan S, Chen Z, Yang Q, et al. (2012) Suppression of experimental choroidal neovascularization by curcumin in mice. PLoS One 7(12):e53329. doi: 10.1371/journal.pone.0053329.